<DOC>
	<DOCNO>NCT02330432</DOCNO>
	<brief_summary>Recent evidence suggest sepsis continuum include immune paralytic state , may play significant role sepsis . Mycobacterium w TLR4 agonist activity may help restore immunity , thereby improve outcome patient severe sepsis . In randomized trial , investigator propose evaluate efficacy Mw patient severe sepsis .</brief_summary>
	<brief_title>Mycobacterium w Patients With Severe Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<criteria>Patients severe sepsis within 48 hour first organ dysfunction Cardiovascular system dysfunction : systolic blood pressure ≤90 mm Hg mean arterial pressure ≤70 mm Hg least one hour despite adequate fluid resuscitation use vasopressor maintain systolic blood pressure mean arterial pressure &gt; 90 &gt; 65 mm Hg , respectively Renal dysfunction : urine output &lt; 0.5 ml/kg/hour two consecutive hour despite adequate fluid resuscitation Respiratory system dysfunction : PaO2/FiO2 ≤300 ≤250 lung sepsis Hematologic dysfunction : platelet count &lt; 100,000/mm3 decrease 50 % three day precede enrollment Unexplained metabolic acidosis : pH ≤7.30 Pregnancy Grampositive culture Only fungal infection source sepsis Patients receive cardiopulmonary resuscitation Those immunosuppressive therapy Those unwilling provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>